Medicine & Life Sciences
Neonatal Screening
100%
Lysergic Acid Diethylamide
56%
Late Onset Disorders
21%
Lysosomal acid lipase deficiency
16%
Type A Niemann-Pick Disease
15%
Cerebrotendinous Xanthomatosis
14%
Ceroid
14%
Ethical Analysis
13%
Metachromatic Leukodystrophy
13%
Cost Sharing
13%
Bioethics
12%
Fabry Disease
12%
Gaucher Disease
12%
Lysosomal Storage Diseases
10%
Information Dissemination
10%
Phenotype
10%
Advisory Committees
9%
Glycogen Storage Disease Type II
9%
Translational Medical Research
9%
Industry
8%
Mass Screening
7%
Acids
6%
Natural History
6%
Incidence
6%
Newborn Infant
6%
Ethics
6%
Technology
5%
Biomarkers
5%
Costs and Cost Analysis
5%
Delivery of Health Care
5%
Psychology
5%
Population
5%